Infectious Diseases 1104 - Infectious Disease Alert - Apr 01, 2007

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Associate Editors
Dean L. Winslow, MD, FACP
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine
Section Editor, HIV

Joseph F. John, Jr., MD, FACP, FIDSA, FSHEA
Associate Chief of Staff for Education
Ralph H. Johnson Veterans Administration Medical Center
Professor of Medicine
Medical University of South Carolina
Charleston, SC

Hal B. Jenson, MD
Chief Academic Officer
Baystate Health Professor of Pediatrics
Dean of the Western Campus of Tufts University School of Medicine

Subjects:

  • Posaconazole for Azole-Refractory Candidiasis in Patients with HIV Infection
  • Azithromycin for Traveler's Diarrhea in Thailand
  • Advisory Committee on Immunization Practices Issues Guidelines for Gardasil, HPV Vaccine
  • RotaTeq Safety
  • Metabolic Syndrome in HIV-Infected Patients
  • Flu Then Flu Now: New Estimates on Pandemic Influenza Deaths
  • Varicella Vaccine, Breakthrough Varicella, and Duration of Immunity
  • Pneumococcal Vaccine and Antimicrobial Resistance in Children
  • Updates

Objectives:

  • To discuss the diagnosis and treatment of infectious diseases
  • To present current data regarding use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • To present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • To discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapy

Financial Disclosure:

Infectious Disease Alert’s Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Peer Reviewer, Connie Price, MD, reports no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company related to this field of study.

Updates Author, Carol A. Kemper, MD, FACP, reports no financial relationships relevant to this field of study.

Associate Editor, Dean L. Winslow, MD, FACP, serves as a consultant to Siemens Diagnostics and is on the Speakers Bureaus of Boehringer-Ingelheim and GSK.

Associate Editor, Joseph F. John, Jr., MD, FACP, FIDSA, FSHEA, does research for Merck, is a consultant for Cubist, Roche, and bioMerieux, and is on the speaker's bureau for Pharmacia, GSK, Merck, Bayer, and Wyeth.

Associate Editor, Hal B. Jenson, MD, is on the speaker's bureau for Merck.

Copyright 2007 AHC Media. All rights reserved.